Which hedge funds own CRSP? CRISPR THERAPEUTICS AG, Q2 2026 13F holders
36 tracked hedge funds disclosed a position in CRSP (CRISPR THERAPEUTICS AG) in their Q2 2026 13F filings, worth $350.6m in total. The largest holder by portfolio weight is EcoR1 Capital, LLC at 3.8% of its book. 13 opened a new position this quarter: Encore Global Management, LP, Logos Global Management LP, Campbell & CO Investment Adviser LLC, Fox Run Management, L.L.C.. 5 exited: Alpine Woods Capital Investors, LLC, Readystate Asset Management LP, Gsa Capital Partners LLP.
- 36
- Holders Tracked managers whose filing for the quarter reports a long equity position in the security.
- 13
- New this quarter Holders whose previous filing (at most two quarters earlier) did not report the security.
- 5
- Exited this quarter Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
- $75.1m
- Inflow, new holders Combined value of the positions the new holders reported for the quarter.
- $2.1m
- Outflow, exits Combined value the exiting managers reported for the security in their previous filing.
- $351m
- Combined value Sum of the holders' reported positions in the security.
- 2.9%
- Share of managers holding Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.
Holders, Q2 2026
Exited since the previous filing
| Alpine Woods Capital Investors, LLC | 0.09% | $391k |
| Readystate Asset Management LP | 0.06% | $996k |
| Gsa Capital Partners LLP | 0.03% | $462k |
| SummitTX Capital, L.P. | 0.01% | $212k |
| Wolverine Asset Management LLC | 0.0% | $72.4k |
Ownership over time
Who discovered CRSP first? Beta
The run: Q2 2017 → Q2 2018, +267%
| Cormorant Asset Management, LP | Q1 2019 | – | +3.5 pts |
| EcoR1 Capital, LLC high conviction | Q1 2019 | – | +2.0 pts |
| Valiant Capital Management, L.P. | Q2 2019 | – | +1.9 pts |
| Casdin Capital, LLC | Q1 2018 | – | +1.2 pts |
| Armistice Capital, LLC | Q3 2019 | – | +0.8 pts |
| Peconic Partners LLC | Q3 2019 | – | +0.3 pts |
| Alpine Woods Capital Investors, LLC | Q4 2020 | – | −0.1 pts |
| Ikarian Capital, LLC | Q2 2021 | – | −0.8 pts |
Split-adjusted quarter-end prices, excluding dividends. They describe the stock while each manager held it, not the return it earned.